Conference Coverage
Conference Coverage
Natalizumab switch to moderate-efficacy DMT increases disability risk
“Patients transitioning from natalizumab to another high-efficacy therapy have better inflammatory and disability outcomes, compared with those...
Conference Coverage
High levels of air pollution linked to increased MS risk
“Countermeasures that cut air pollution can be important for public health, not only to reduce deaths related to cardiac and pulmonary diseases...
Conference Coverage
Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease
One of two “identical studies” assessing a novel treatment in development for Alzheimer’s disease reports significant efficacy, while the other...
Conference Coverage
Galcanezumab looks promising for treatment-resistant migraine
The monoclonal antibody reduced the mean number of monthly migraine days in a 3-month open-label extension of the phase 3 CONQUER study.
Conference Coverage
Chronic migraine is associated with changes in the amygdala
Changes in the volume and connectivity of the amygdala are associated with headache frequency and affective states.
Conference Coverage
COVID-19: Psychiatrists assess geriatric harm from social distancing
“Certainly the appalling number of deaths in nursing homes is the No. 1 horror of the pandemic.”
Conference Coverage
Social isolation tied to higher risk of cardiovascular events, death
“These results are especially important in the current times of social isolation during the coronavirus crisis.”
Conference Coverage
COVID-19 vaccine won’t be a slam dunk
A key safety concern to watch for in the coming months is whether a vaccine candidate is able to sidestep the issue of antibody-dependent...
Conference Coverage
TNF inhibitors may dampen COVID-19 severity
New findings from the COVID-19 Global Rheumatology Alliance Registry.
Conference Coverage
New research confirms the efficacy and safety of onasemnogene abeparvovec for SMA
Three investigations indicate that the treatment allows children, including those who are presymptomatic, to achieve and maintain motor milestones...
Conference Coverage
Frontal lobe glucose abnormalities may indicate increased SUDEP risk
The idea is to identify those at high risk and then reduce that risk with more aggressive management of seizures or closer monitoring in certain...